Belite Bio (BLTE) Stock Chart & Stock Price History $61.81 -3.14 (-4.83%) Closing price 08/19/2025 04:00 PM EasternExtended Trading$62.50 +0.70 (+1.12%) As of 08/19/2025 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Belite Bio Stock Price Performance The Belite Bio (BLTE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 24.64%, with a year-to-date return of -2.04%. In the past month, the stock has increased 1.46%, reflecting recent market activity. As of the latest close, Belite Bio traded at $61.81 with a market cap of $1.97 billion and volume of 82,961 shares. Receive BLTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Belite Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.23%1 Month Performance+1.46%3 Month Performance-4.63%Year-To-Date Performance-2.04%1 Year Performance+24.64% BLTE Stock Chart for Wednesday, August, 20, 2025 BLTE Chart by TradingView Belite Bio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/19/2025$64.95$61.81-4.83%$64.56$60.1182,961 shs$1.97 billion08/18/2025$66.63$64.95-2.52%$67.89$64.6335,902 shs$2.07 billion08/15/2025$68.98$66.63-3.41%$70.26$66.6344,722 shs$2.12 billion08/14/2025$71.56$68.98-3.61%$70.96$68.78104,715 shs$2.20 billion08/13/2025$72.73$71.56-1.61%$73.83$70.8253,213 shs$2.28 billion08/12/2025$69.50$72.73+4.65%$74.49$69.4759,772 shs$2.32 billion08/11/2025$69.88$69.50-0.54%$74.00$68.9960,869 shs$2.21 billion08/08/2025$70.09$69.88-0.30%$73.90$69.0241,565 shs$2.22 billion08/07/2025$67.99$70.09+3.09%$74.00$67.30141,300 shs$2.23 billion08/06/2025$66.31$67.99+2.53%$68.00$64.9651,402 shs$2.16 billion Get the Latest News and Ratings for BLTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Belite Bio and its competitors with MarketBeat's FREE daily newsletter. 08/05/2025$69.79$66.31-4.99%$69.09$64.8543,552 shs$2.11 billion08/04/2025$65.72$69.79+6.19%$69.79$65.8620,328 shs$2.22 billion08/01/2025$65.01$65.72+1.09%$66.11$63.4041,269 shs$2.09 billion07/31/2025$64.81$65.01+0.31%$65.36$63.3448,795 shs$2.07 billion07/30/2025$63.59$64.81+1.92%$65.25$63.5930,552 shs$2.06 billion07/29/2025$62.05$63.59+2.48%$63.95$62.0812,620 shs$1.98 billion07/28/2025$62.24$62.05-0.31%$62.38$61.5010,234 shs$1.98 billion07/25/2025$61.85$62.24+0.63%$62.48$61.0220,602 shs$1.98 billion07/24/2025$62.31$61.85-0.74%$62.48$61.0122,622 shs$1.97 billion07/23/2025$59.67$62.31+4.42%$62.37$60.3721,150 shs$1.98 billion07/22/2025$61.30$59.67-2.66%$62.64$59.12132,211 shs$1.90 billion07/21/2025$60.92$61.30+0.62%$62.60$61.2044,334 shs$1.95 billion Related Companies BPMC Stock Price Chart ELAN Stock Price Chart ROIV Stock Price Chart GRFS Stock Price Chart LEGN Stock Price Chart RVMD Stock Price Chart RYTM Stock Price Chart RNA Stock Price Chart NUVL Stock Price Chart ABVX Stock Price Chart Receive BLTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Belite Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BLTE) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersWinning the AI WarWhat’s really driving the trade wars, reshoring, and sweeping executive orders? According to Porter Stansberry...Porter & Company | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Belite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access